Variables | Category | Frequency | Percentage (%) |
---|---|---|---|
Initial regimen | TDF-3TC-EFVa | 264 | 63.2 |
TDF-3TC-NVPb | 8 | 1.9 | |
AZT-3TC-EFVc | 72 | 17.2 | |
AZT-3TC-NVPd | 56 | 13.4 | |
ABC-3TC-EFVe | 18 | 4.3 | |
Number of ART pills | One pill/day | 311 | 74.4 |
> one pill/day | 107 | 25.6 | |
Functional status | Working | 362 | 86.6 |
Ambulatory | 41 | 9.8 | |
Bedridden | 15 | 3.6 | |
Baseline WHO clinical stage | I | 186 | 44.5 |
II | 77 | 18.4 | |
III | 76 | 18.2 | |
IV | 79 | 18.9 | |
Baseline CD4 count | < 100 cells/mm3 | 88 | 21 |
100–199 cells/mm3 | 78 | 18.7 | |
200–349 cells/mm3 | 97 | 23.2 | |
> = 350 cells/mm3 | 155 | 37.1 | |
Adherence | Good | 353 | 84.4 |
Fair | 32 | 7.7 | |
Poor | 33 | 7.9 | |
Past OI | Yes | 36 | 8.6 |
No | 382 | 91.4 | |
CPT prophylaxis | Yes | 222 | 53.1 |
No | 196 | 46.9 | |
Baseline hemoglobin | < 7 g/dl | 1 | 0.2 |
7–9.9 g/dl | 13 | 3.1 | |
10–12.9 g/dl | 97 | 23.2 | |
≥ 13 g/dl | 307 | 73.4 | |
Viral load | < 1000 copies/ml | 366 | 87.6 |
> = 1000 copies/ml | 52 | 12.4 | |
TB infection | Yes | 83 | 19.9 |
No | 335 | 80.1 | |
Co-medication | Yes | 120 | 28.7 |
No | 298 | 71.3 |